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Synthetic biology is an emerging field of interdisciplinary 
research that seeks to transform our ability to probe, 
manipulate, and interface with living systems by 
combining the knowledge and techniques of biology, 
chemistry, computer science, and engineering. Its main 
aim is to increase the ease and efficiency with which 
biological systems can be designed, constructed, and 
characterized. Core efforts in the field have focused on 
the development of tools to support this goal, including 
new approaches to biological design and fabrication. 
Although the first generation of synthetic systems 
demon strated genetic circuits that encode dynamic 
behavior, cellular computational operations, and bio­
logical communication channels, more recent research 
has focused on implementing synthetic biological devices 
and systems in diverse applications, including disease 
therapy, environmental remediation, and biosynthesis of 
commodity chemicals. As the field matures, synthetic 
biology is advancing biological frontiers by expanding 
biomanufacturing capabilities, developing next­genera­
tion therapeutic approaches, and providing new insights 
into natural biological systems. Here, we review the 
theoretical foundations, diverse tool kits, and engineered 
systems that have emerged from synthetic biology and 
discuss current as well as potential future applications, 
which include in­depth studies of basic biology (such as 
understanding endogenous signaling pathways and 
feedback circuits) and new frontiers in health and medi­
cine (such as identification of diseased cells and targeted 
therapeutics).
Conceptual frameworks for biological design
A central aim of synthetic biology is to increase the ease 
and efficiency with which biological systems can be 
designed, constructed, and characterized. Although the 
manipulation of biological organisms and molecular 
pathways long preceded the emergence of synthetic 
biology, the engineering of biological systems has been a 
largely ad hoc exercise. A main reason is that biology is 
inherently diverse, mutable, and context specific. Natural 
biological substrates, including genetic elements such as 
promoters and genes, do not always behave predictably 
when implemented in different combinations, and details 
such as how individual parts are physically connected can 
vary widely across different construction methods. As a 
result, the components designed and assembled for one 
biological system often cannot be predictably reused in 
another system. Synthetic biology seeks to address this 
challenge by implementing a more ‘engineering­ready’ 
conceptual framework that emphasizes the need to 
generate and report biological constructs in a manner 
that is conducive to their understanding and utilization 
by a broad community of researchers.
The application of engineering tools such as abstrac­
tion, decoupling, and standardization was proposed early 
in the emergence of synthetic biology to support the 
efficiency and scaling of the biological system design 
process [1]. An abstraction hierarchy that dissects the 
engineering process into several design levels ­ DNA, 
parts, devices, and systems ­ provides synthetic biologists 
with a means to manage complexity and distribute tasks. 
The design process at each abstraction level can be 
performed relatively independently of the other levels, 
and detailed information critical to one abstraction level 
need only be considered by designers operating at that 
level. This division of labor reduces the amount of infor­
ma tion that each designer must be expert in to success­
fully design a part, device, or system.
Decoupling refers to the strategy of partitioning a 
complicated problem into simpler tasks that can be 
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tackled separately and assembled into a complete 
solution. The separation of design and fabrication pro­
cesses is an important example of decoupling supported 
by advances in design tools and fabrication platforms. 
The increasing efficiency and decreasing cost of DNA 
synthesis allow synthetic biologists to design novel 
systems with the confidence that DNA components can 
be readily synthesized by commercial sources. Further­
more, advances in DNA sequencing and synthesis pro­
vide researchers with access to biological components 
encoding functions of interest using sequence informa­
tion deposited in databases, eliminating the need for 
physical exchange of genetic materials.
Standardization takes several forms, including standardi­
zation of physical assembly, functional assembly, and 
characterization/measurements. Early physical assembly 
standards used biological parts flanked by standardized 
sequences, enabling the interchangeable combination and 
sequential assembly of parts conforming to the specified 
standard through a constant restriction­enzyme/ligation­
mediated cloning strategy [2,3]. Significantly less progress 
has been made in the field on functional assembly 
standards, which focus on identifying sequence interfaces 
between two types of parts (for example, ribosome bind­
ing site (RBS) and gene) that allow functional coupling 
and predictable activity, independent of the specific 
sequence of each part. Several early physical­assembly 
strategies encountered obstacles because the proposed 
standards impaired the functional assembly of parts by 
requiring the insertion of standard sequences between 
each part. In response, the field is shifting to assembly 
methods that do not require restriction­enzyme­
mediated cloning [4,5]. Finally, technical measurement 
and reporting standards have been proposed to eliminate 
discrepancies that result from disparate experimental 
methods and to provide more reliable and thorough 
characterization data [6]. Standardized characterization 
data will support reliable sharing and reuse of parts, 
devices, and systems such that new designs can build on 
the foundation of previous work and move beyond the ad 
hoc model of system development.
Advances in fabrication methods for genetic 
systems
As synthetic biological systems become increasingly 
sophisticated, fabrication methods with larger capacities, 
greater precision, higher speed, and lower cost have 
become increasingly important. Outpacing the develop­
ment of novel parts and devices, a number of ground­
breaking fabrication techniques have been demonstrated 
in recent years, allowing researchers to focus on system 
design while outsourcing or performing system fabrica­
tion with higher efficiencies than was previously possible. 
Advances in multiplex oligonucleotide synthesis and 
assembly with microfluidic arrays have allowed cheaper 
de novo synthesis of gene­length fragments [7­9]. 
Further more, several techniques have been developed for 
the assembly of large DNA fragments, moving the field 
beyond laborious and time­consuming molecular cloning.
For example, transformation­associated recombination 
(TAR) in the yeast Saccharomyces cerevisiae has been 
used to construct yeast artificial chromosomes encoding 
genes and pathways isolated from several different 
organisms [4,10]. Yeast artificial chromosomes can be 
further modified with bacterial artificial chromosome 
sequences to transfer the constructs to bacteria and 
subsequently to mammalian cells [11]. Enzymatic in vitro 
assembly methods, such as one­step isothermal DNA 
assembly, can allow DNA molecules of several hundred 
kilobases to be assembled without restriction­enzyme­
mediated digestion [5,12]. A combination of in vitro and 
TAR­based assembly methods was used to assemble and 
clone the first bacterial genome from chemically syn the­
sized oligonucleotides [13]. However, large sets of parts 
encoding similar functions with distinct sequences are 
needed to avoid undesired recombination events between 
components that share similar sequences when assemb­
ling large genetic systems with recombination­based 
strategies.
In addition to DNA synthesis and assembly, methods 
have been developed for high­throughput genome 
modification. Multiplex automated genome engineering 
(MAGE) uses the bacteriophage λ­Red single­stranded­
DNA­binding protein β to achieve allelic replacement in 
Escherichia coli. This process can greatly accelerate the 
optimization of biological systems and metabolic path­
ways, provided that the target genes are known and that 
an efficient screening method is in place to identify the 
desired variants within the diverse libraries generated 
[14]. An alternative method termed trackable multiplex 
recombineering (TRMR) has been developed to support 
applications in which a priori knowledge of which target 
gene to modify is lacking, enabling rapid mapping of 
genes and quantification of population dynamics [15]. A 
complementary technology called hierarchical conjuga­
tive assembly genome engineering (CAGE), which has 
been used to combine portions of a genome that have 
been modified by MAGE, was also recently described 
[16]. Although genome modification has been reported 
in yeast [17], most high­throughput methods have been 
limited to demonstrations in E. coli and the extension of 
these technologies to mammalian cells remains an 
impor tant challenge.
Constructing the toolbox: synthetic biological 
parts and devices
Over the past decade, the synthetic biology community 
has built a large collection of biological parts and devices 
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with diverse functions [18] (Table 1). One focus has been 
the development of control devices that alter protein 
levels in response to prescribed input signals, supporting 
the ability to reprogram cellular behavior. Most systems 
demonstrated so far use transcription­based control, 
incorporating constitutive and inducible promoters from 
a small set of well­characterized parts, such as the 
tetracycline­ and isopropyl­β­d­thio­galactoside (IPTG)­
inducible promoters. However, inadequacies in these 
often­used promoters, including inducer toxicity and 
limited selection of input choices and response profiles, 
have motivated the development of libraries of consti tu­
tive promoters with varying strengths [19,20] and the 
generation of new inducible promoters respon sive to 
small molecules [21], gaseous acetaldehyde [22], and light 
[23]. The expanding collection of promoter parts 
increases the range of stimuli and expression levels that 
can be achieved, providing greater flexibility in control­
ling the behavior of biological systems.
As the diversity of gene regulatory processes in natural 
biological systems comes to light, efforts have also been 
directed to developing control devices that act through 
posttranscriptional and posttranslational mechanisms. In 
addition to parts such as degradation tags [24,25] and 
split inteins [26,27], non­coding regulatory RNAs have 
been used to construct a number of control devices [28]. 
In one example, microbial gene expression was regulated 
by engineered RNA­responsive regulators (termed ‘ribo­
regulators’) that modulate translation initiation by either 
obstructing or releasing the RBS of a target gene in 
response to the presence of a separately transcribed RNA 
sequence [29]. Researchers have demonstrated the utility 
of riboregulators in a variety of applications, including 
protein localization studies, perturbation of stress 
response networks, and programmable cell killing [30]. 
RNA­based devices responsive to small­molecule and 
protein inputs have also been demonstrated, exerting 
control over both transgenic and endogenous protein 
expres sion in bacteria, yeast, and mammalian cells 
[31­33], leading to applications ranging from bacteria­
mediated detection and breakdown of pesticides [34] to 
disease­marker detection and cell­fate regulation in 
mam malian cells [35]. The unique properties of RNA­
based control devices ­ including ease of design and con­
struction, small genetic footprint, high energy efficiency, 
fast regulatory time scales, and the ability to tailor input 
responsiveness and regulatory stringency  ­ have made 
RNA a versatile substrate for designing programmable 
control systems.
In addition to controlling protein levels, synthetic 
biologists have developed tools to modulate the spatial 
organization of protein molecules inside cells, resulting 
in new strategies for regulating or rewiring cellular 
activities encoded in metabolic and signaling pathways 
[36]. In one example, researchers constructed synthetic 
feedback loops within the yeast mating mitogen­
activated protein (MAP) kinase pathway by recruiting 
modulator proteins to the pathway scaffold protein Ste5 
through fusing leucine zipper domains to each compo­
nent, and demonstrated circuits with pulse generator, 
accelerator, delay, and ultrasensitive switch functions 
[37,38]. In another example, synthetic protein scaffolds 
that spatially recruit metabolic enzymes were imple men­
ted in E. coli, enabling the stoichiometric optimiza tion of 
three mevalonate biosynthetic enzymes and achieving a 
77­fold increase in product titer while avoiding cellular 
toxicity caused by the accumulation of a pathway inter­
mediate [39]. As an alternative to protein­based scaffolds, 
rationally designed RNA strands have recently been 
shown to assemble into higher­order structures, 
Table 1. The synthetic biology toolbox: common components used in synthetic biological systems
	 Component	 Function
Transcriptional Constitutive promoter libraries [19,20] Provide continuously ON gene expression at pre-determined levels
 Inducible promoters (for example, responsive to tetracycline,  Provide conditional and, in certain cases, titratable gene expression 
 IPTG, gaseous acetaldehyde [22], or light [23]) in response to inducer signal
Posttranscriptional Non-coding regulatory RNAs [28] (such as riboregulators  Control protein production levels by regulating mRNA stability or
 [29,30], ribozyme switches [31,51], and RNAi switches [32,33]) translation initiation in response to molecular input
 Alternative splicing modulators [35] Control protein production levels or protein activity by regulating  
  alternative splicing of mRNA in response to molecular input
 RNase substrate libraries [80] Control protein levels through tunable hairpin elements that direct  
  transcript cleavage
Posttranslational Degradation tags [24,25] Modulate protein levels by shortening protein half-lives
 Split inteins [26,27] Provide biosensing and modulate protein activity by conditionally  
  splicing inactive protein fragments together into functional wholes
Structural Protein [36-39], RNA [40], and DNA [93] scaffolds Regulate signaling and metabolic pathway flux by controlling the 
  localization and stoichiometry of pathway components and  
  intermediate products
IPTG, isopropyl-β-d-thio-galactoside; RNAi, RNA interference.
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includ ing sheets and nanotubes, inside bacterial cells 
[40]. An RNA scaffold was applied to a two­enzyme 
hydrogen biosynthesis pathway and shown to increase 
hydrogen production by up to 48­fold compared with an 
un scaff olded system [40]. These examples highlight the 
utility of spatial engineering in enhancing and modifying 
bio logical pathways.
Synthetic gene circuits
One of the hallmarks of synthetic biology has been the 
drive to engineer biological systems from the bottom up. 
Model­driven design of synthetic gene circuits has 
demon strated the ability to build circuits of specified 
function [41­43]; differences between models and realized 
circuits have illuminated important and unique aspects 
of biological system behavior, such as the effects of 
degradation processes, cooperativity, and noise [44­46]. 
In addition to inspiring the design of more robustly 
operating systems, the insights gained through synthetic 
approaches have contributed to our understanding of 
natural biological systems [47].
Genetic	circuits	encoding	dynamic	behaviors
The construction of two genetic circuits encoding dynamic 
behavior, the repressilator [44] and the toggle switch [48], 
marked two early efforts in genetic circuit design in 
synthetic biology. The repressilator, a three­ring oscillator 
built from a loop of three repressor­promoter pairs, 
demonstrated that an oscillatory response could be 
generated from biological parts not found in natural 
biological oscillators. However, the synthetic oscillator 
showed fluctuations and heterogeneity not observed in 
natural circadian oscillators, which generally use inter­
linked positive and negative feedback loops [45]. Subse­
quent generations of oscillators have interlinked positive 
and negative transcriptional feedback loops of different 
strengths to drive more robust oscillatory dynamics with 
tunable periods and amplitudes in bacterial [42] and 
mammalian cells [49] (Figure  1a). In the post­genomics 
era, the importance of precise timing and coordination of 
gene expression in regulating systems­level behavior is 
increasingly appreciated. Well­defined, synthetic gene 
circuits that control the temporal profile of gene expres­
sion can elucidate the contributions of expression 
dynamics to natural time­dependent processes, such as 
cell signaling, cell­fate determination, and development. 
Synthetic gene circuits also offer the potential to develop 
genetically encoded strategies for intervening and 
controlling these natural processes.
Encoding	cellular	logic	and	computing	functions
Genetic circuits that perform computations and logical 
evaluations of cellular information provide the ability to 
assess intracellular states and environmental signals. 
They transmit this information into changes in cellular 
function, such as production of easily assayed readouts, 
activation of metabolic pathways, or initiation of cell­fate 
decisions. Towards this goal, genetic circuits and devices 
capable of performing logical evaluations have been built 
to detect small molecules (using tandem promoter 
systems [50] and RNA devices [51]), and small RNAs 
such as small interfering (si)RNAs (using tandem RNA 
interference (RNAi) target sites [52]) (Figure  1b). These 
various schemes have demonstrated the classic NOT, 
OR, NOR, and AND gates that are used to build larger 
logic evaluators and computations.
Methods for counting and maintaining memory of 
system states will enable a broader spectrum of intra­
cellular computing. A genetic circuit that can count up to 
three exposure events to a small­molecule inducer was 
built in bacteria by nesting polymerase­promoter pairs 
controlled by riboregulators responsive to an inducible 
transactivator [53]. Although this system captured brief 
induction pulses, system performance was highly depen­
dent on pulse duration and frequency. The incorporation 
of genetic memory offers an alternative strategy to increase 
the robustness of counting events over longer time frames. 
A three­event counter circuit was demon strated by using 
DNA recombinase­based cascades that record each event 
as a permanent change to the DNA, where the output of 
each recombinase event would ‘prime’ the next promoter­
recombinase pair in the circuit [53]. Synthetic networks of 
feedback loops have been built as memory circuits that 
lock a system in one state through sustained production of 
proteins following a transient signal that initiates the state. 
For example, toggle switches engineered to show bistability 
in bacteria [48] and mammalian cells [54] use architectures 
of mutually inhibitory feedback loops to achieve reversible 
memory of small­molecule pulses. As another example, a 
positive feedback loop built from a synthetic trans­
criptional activator cascade demonstrated heritable 
memory over many generations in yeast [55].
One recurrent limitation in adapting biological systems 
to perform computation through the rules of binary logic 
is the analog nature of the responses. In particular, gene 
expression leakage in the OFF state can contribute to 
improper input processing and high basal output, 
diminishing an evaluator’s signal­to­noise ratio 
[48,53,55]. In addition, control of highly lethal proteins 
and proteins that mediate irreversible genetic changes 
requires stringent OFF states. To address this issue, 
researchers have layered transcriptional and post­
transcriptional control elements within genetic circuits 
to provide strategies for achieving stringent regulation of 
transgenes in mammalian [56,57] and bacterial cells [30]. 
In one example, an inducible promoter was layered with 
repressible expression of a small hairpin (sh)RNA to 
achieve undetectable expression levels of the highly lethal 
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diphtheria toxin in the OFF state, thus enabling induced 
cell death only in the ON state [56]. Although tight OFF 
states are desirable for binary computing, biological 
computing necessarily exploits the analog and tunable 
nature of gene expression. Connecting logical circuit 
outputs to changes in cellular state requires the ability to 
Figure	1.	Synthetic	circuits	that	perform	diverse	functions	can	be	coupled	to	achieve	higher-order	responses. (a)	Interlinked positive 
and negative feedback loops of different strengths drive an oscillatory response. Arabinose-responsive transcriptional activator (AraC) expression 
positively modulates gene expression and results in a positive feedback loop, whereas the isopropyl-β-d-thio-galactoside (IPTG)-responsive inhibitor 
of the lac promoter (LacI) inhibits expression and generates a negative feedback loop. The small-molecule inducers arabinose and IPTG modulate 
the strength of these feedback loops [42]. GFP, green fluorescent protein. (b) A mammalian AND gate composed of RNA interference (RNAi) target 
sites evaluates small interfering (si)RNA inputs. Unique RNAi target sites are placed in the 3’ UTR of two lacI genes, and LacI regulates the expression 
of a fluorescent reporter, resulting in an AND logic evaluator for the siRNA inputs m1 and m2 [52]. YFP, yellow fluorescent protein. (c) Quorum-
sensing circuitry allows population control. Cell density is broadcast by the diffusible small molecule acyl-homoserine lactone (AHL), which is 
synthesized by the enzyme LuxI (X). As cell density and AHL concentration increase, LuxR (R), a transcriptional regulator, binds AHL and initiates 
expression of a ‘killer’ gene (encoding CcdB, a lethal protein that targets the DNA gyrase complex), ultimately reducing the steady-state cell density 
[58]. (d) Interlinking positive and negative feedback loops with communication circuitry enables oscillation synchronization across a population 
of cells. Expression of R positively regulates expression of X, R, GFP, and AiiA (A), an enzyme that degrades AHL. As A increases in concentration, 
it degrades AHL and negatively modulates protein expression levels [62]. (e) Combining logic processing with communication circuitry enables 
a synthetic biological edge detection system. The expression of X and the transcriptional repressor cI (Y) is turned ON in cells in the dark region, 
where Y represses the expression of the pigment-producing protein (pigment: β-galactosidase, an enzyme that cleaves a substrate to produce 
a black pigment). However, diffusion of AHL synthesized by cells in the dark region activates R in cells at the edge of the light region (where Y is 
turned OFF), thus turning ON expression of pigment only in cells along this edge [63].
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both identify thresholds of expression at which cellular 
behavior diverges and tune the output to cross that 
threshold when triggered. Combining the computational 
ability of logical evaluators with improved strategies for 
leakage minimization and output tuning should enable 
more robust computing. These tools can expand our 
ability to detect and treat diseases by increasing diag­
nostic certainty and improving precision in gene expres­
sion, and can also be used to probe previously 
inaccessible information sets, such as the temporal and 
spatial profiles of particular developmental genes, which 
will inform our fundamental understanding of biology.
Communication	circuits	supporting	more	complex	
behaviors
Communication systems are required to coordinate 
events and tasks between different cells in a population. 
Synthetic communication circuits have been engineered 
in bacteria using various bacterial quorum­sensing 
systems. In these systems, a lactone signal is broadcast 
with increasing strength as cell density increases. At a 
given threshold level, lactone binds and activates a 
transcriptional regulator, upregulating the expression of a 
target gene. Broadcasting and receiving can be incor­
porated within a single cell population or distributed 
between ‘sender’ and ‘receiver’ cells. Incorporating both 
functions in a single population programmed to regulate 
a killer gene resulted in population control and demon­
strated how population heterogeneity can be exploited to 
achieve a robust population response [58] (Figure  1c). 
Segregating tasks and localizing the sender population 
established a radial gradient of signaling molecules. 
Coupling the quorum­sensing circuitry to a band­pass 
circuit, which detects a specified range of input concen­
trations, achieved formation of various radial patterns in 
the receiver cells [59]. In addition, connecting bacterial 
quorum systems to synthetic circuits has demonstrated 
dual­population consensus response and symbiosis in 
biofilms [60,61] and synchronized genetic clocks [62] 
(Figure  1d). Finally, coupling a light­responsive device 
[23] to logic­processing circuitry and a communication 
module resulted in a biological edge detector [63] 
(Figure  1e). These examples demonstrate how synthetic 
circuits can distribute and coordinate computational 
tasks across a population of cells to achieve complex 
responses similar to what is observed in natural pattern 
formation and development.
Beyond bacterial systems, mammalian receiver cells 
have been engineered to respond to volatile chemical 
signals [64] and metabolic conditions [65] using engi­
neered synthetic promoters. These receivers can poten­
tially be paired with various processing circuits and sender 
cells to generate synthetic hormone­signaling systems and 
synthetic ecosystems. The eventual coupling of metabolic 
functions and cell­fate circuitry to synthetic hormone­
signaling systems will enable spatial patterning of cell 
differ entiation and timing of coordinated cellular responses, 
a requisite for complex tissue formation and function.
Moving towards real-world applications
Despite remarkable advances in the design and con­
struction of increasingly sophisticated genetic circuits 
over the past decade, the transition of these systems to 
real­world applications has been constrained by the 
limited availability of devices that can connect synthetic 
circuitry with information in living systems. However, 
synthetic biologists are developing new ways to connect 
natural and engineered systems. For example, exploiting 
existing connections between synthetic circuitry and 
intra cellular information, researchers have used the 
natural correlation between DNA damage and proteolysis 
of the ON state inhibitor λ cI in a genetic toggle switch to 
record transiently induced DNA damage through the 
formation of a biofilm [66]. Taking another approach, 
researchers have constructed synthetic sensor devices 
from natural components, such as promoter­repressor 
pairs [67,68], signaling pathway components [69], and 
small RNAs and their target sites [52,57], to extract infor­
mation from biological systems. As the range of sensor 
devices, processing circuitry, and output modules expands, 
synthetic biology is poised to address a broad scope of 
biological, medical, and biotechnological challenges.
Understanding	biology	by	building
The ability to construct synthetic genetic circuits from 
the bottom up has enabled researchers to approach 
questions in basic biology from a new angle. Instead of 
perturbing natural pathways or model systems, biological 
systems can be probed by constructing artificial circuits 
and examining their behavior and interactions with endo­
genous machinery [70]. For example, in one investigation 
into why a particular circuit architecture was selected 
over others that produced similar dynamics, researchers 
compared the native Bacillus subtilis circuit that 
regulates differentiation into the competence state (when 
cells can take up DNA from the environment) with an 
engineered circuit [71] (Figure 2a). Modeling and empi­
rical results both indicated that, despite generating 
excitable dynamics with similar shapes and frequency to 
those of the native competence circuit, the engineered 
circuit achieved greater precision in the duration of 
competence. It was further demonstrated that the greater 
variability in the native circuit conferred an advantage in 
the form of more consistent transformation efficiency 
over a large range of extracellular DNA concentrations, 
highlighting the effective exploitation of noise in natural 
circuits [71]. Additional synthetic circuits have been 
constructed to study the modularity and plasticity of 
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MAP kinases [72,73] and the interaction between Notch 
and Delta critical for cell patterning during development 
[74], among others [70], illustrating the utility of syn­
thetic biology in expanding our fundamental understand­
ing of biology.
Expanding	biomanufacturing	capabilities
Biomanufacturing is one of the more compelling and 
immediate applications of biotechnology that promises 
sustainable synthesis strategies for alternative energy 
sources, commodity chemicals, and high­value specialty 
chemicals such as therapeutic drugs. A major challenge 
of biosynthetic pathway engineering lies in balancing the 
levels and activities of the many heterologous pathway 
enzymes to achieve optimized productivity and yield of 
desired compounds in the microbial host. Synthetic bio­
logy is transforming biosynthesis capabilities by provid­
ing new tools that support pathway construction and 
Figure	2.	Synthetic	biological	circuits	can	aid	in	understanding	of	biology,	improve	biomanufacturing	productivity,	and	enable	disease-
targeted	therapy. (a) The native circuit regulating competence in B. subtilis was compared with a synthetic circuit with similar dynamics to 
reveal architecture-specific variability in the duration of competence and consequent differences in the consistency of transformation efficiency 
over large ranges of DNA concentration [71]. (b) A synthetic protein scaffold was used to increase the biosynthesis of mevalonate from acetyl-
CoA in E. coli. The scaffold consists of three protein-protein interaction domains (GBD, the GTPase binding domain from the actin polymerization 
switch N-WASP; SH3, the Src homology 3 domain from the adaptor protein CRK; and PDZ, the PSD95/DlgA/Zo-1 domain from the adaptor 
protein syntrophin) in various copy numbers connected by glycine-serine linkers. Pathway enzymes (AtoB, acetoacetyl-CoA thiolase; HMGS, 
hydroxymethylglutaryl-CoA synthase; HMGR, hydroxymethylglutaryl-CoA reductase) were each fused to the ligands of one interaction domain and 
recruited to the protein scaffold [39]. PTET, tetracycline-inducible promoter; PBAD, arabinose-inducible promoter.	(c) A targeted therapeutic circuit was 
constructed by inserting an RNA aptamer near an alternatively spliced exon harboring a stop codon in a three-exon, two-intron minigene fused 
to herpes simplex virus thymidine kinase (HSV-TK). Binding of a disease marker protein to the aptamer results in exclusion of the alternative exon, 
expression of a suicide gene, and killing of diseased cells [35]. PCMV, cytomegalovirus promoter.
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optimization. For example, researchers have recently 
combined TAR­based assembly strategies with sets of 
biosynthetic pathway parts (including enzyme coding 
regions, promoters, and terminators) to demonstrate one­
step, whole­pathway assembly for a variety of natural­
product pathways [75­77]. In another example, combina­
torial libraries of tunable intergenic regions (TIGRs) 
harboring a number of RNA regulatory elements, includ­
ing terminators, RNase cleavage sites, and stabilizing 
hairpins, were assembled in the non­coding regions 
between three heterologous enzymes in the mevalonate 
biosynthetic pathway expressed from a polycistronic 
transcript in E. coli. Researchers screened library variants 
for the TIGR sequences that resulted in optimal relative 
expression levels of each enzyme to increase mevalonate 
production; the best mevalonate producers decreased 
accumulation of a toxic intermediate and increased 
growth rate [78]. Libraries of modular control elements, 
including promoters and RNA regulatory elements, that 
have broad ranges of predictable activities have also been 
generated [19,79]. Recently, a library of RNase cleavage 
elements was used in yeast to titrate a key enzyme and 
thus flux through the endogenous ergosterol pathway, 
which competes with synthetic terpenoid pathways for 
the common precursor farnesyl pyrophosphate [80]. 
Finally, several new tools supporting colocalization of 
heterologous enzymes, such as protein­ and RNA­based 
scaffolds, are being used to develop pathway optimization 
strategies based on spatial engineering [39,40] (Figure 2b).
Advancing	next-generation	therapeutics	and	diagnostics
By developing new strategies to interface with and mani­
pu late natural biological systems, synthetic biology holds 
exciting promise in developing new therapeutic approaches. 
For instance, synthetic biologists are develop ing genetic 
circuits that link therapeutic activities to the detection of 
molecular disease signals to develop targeted thera peu­
tics with increased efficacy and safety. In one example, a 
layered microRNA (miRNA)­ and transcription­factor­
based logic circuit was used to distinguish a cervical 
cancer cell line (HeLa) from other cell lines based on the 
detection of a unique miRNA profile [57]. Positive 
identification of HeLa cells through this logic circuit was 
subsequently linked to either expression of a reporter 
protein, as a model diagnostic device, or expression of a 
protein that led to cell death as a model therapeutic 
device. In another example, to restrict cell death to 
diseased cells showing hyperactive signaling, researchers 
developed protein­responsive RNA devices that could 
detect increased signaling through the NF­κB and Wnt 
pathways and transmit this information into changes in 
the expression of a clinically relevant suicide gene that 
sensitizes cells to an apoptosis­inducing prodrug [35] 
(Figure 2c). These types of autonomous sense­and­control 
circuits offer potential applications in the long­term 
surveillance and intervention of chronic diseases, such as 
gout and diabetes [68,81]. Circuits currently under 
develop ment that link genetic targets to clinician­
modulated external inputs will provide an unprecedented 
level of temporal and spatial control over complex 
therapeutic activities. For example, systems have been 
described that support light­modulated glucose homeo­
stasis [82] and drug­modulated control over in vivo gene 
expression [83] and T­cell proliferation [84].
Where will synthetic biology take us?
The biological parts, genetic circuits, and fabrication 
techniques that have been developed and continue to be 
improved on offer exciting potential in diverse applica­
tions, from environmental engineering to regenerative 
medicine. Synthetic biological systems capable of detect­
ing, reporting, and/or removing hazardous substances 
have been reported [85­88], and their implementation in 
robust host organisms suitable for environmental release 
will provide a new paradigm for environmental remedia­
tion. In the area of health and medicine, synthetic inter­
cellular communication systems that regulate spatial 
patterning, timing of coordinated cellular responses, and 
tissue homeostasis have the potential to make significant 
contributions to tissue engineering. Furthermore, 
synthetic control circuitry may reduce the inherent 
tumori genicity of stem cells [89] and improve the 
efficiency of induced pluripotent stem cell reprogram­
ming [90]. Novel genetic circuits capable of guiding the 
ex vivo construction of complex tissues may be built in 
the foreseeable future as researchers continue to unravel 
the systems biology behind cell­fate decisions [91,92].
Efforts in synthetic biology so far have covered a wide 
range of topics spanning broad conceptual frameworks 
and specific circuit designs, and the future direction of 
synthetic biology is by no means limited to the few areas 
highlighted here. However, a unifying driving force in the 
field has been the desire to efficiently build biological 
systems, whether to improve our fundamental under­
stand ing of biology or to provide solutions for pressing 
global challenges. By developing conceptual frameworks 
and technical tools for the design, construction, and charac­
terization of novel biological systems that can perform 
autonomous functions and interact with natural biologi­
cal systems, synthetic biology is poised to trans form our 
ability to probe, understand, and manipulate biology.
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